captopril has been researched along with Hyperlipoproteinemia Type II in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Davidson, DC; Peart, I; Sangster, M; Turner, S | 1 |
| Beucler, I; Dairou, F; Février, B; Scemama, M | 1 |
| Aleotti, L; Bucci, M; Casini, A; Cicala, C; Cirino, G; D'Armiento, FP; de Nigris, F; Franconi, F; Napoli, C; Roviezzo, F; Somma, P; Zuliani, P | 1 |
1 trial(s) available for captopril and Hyperlipoproteinemia Type II
| Article | Year |
|---|---|
Lipid profile and antihypertensive efficacy in hyperlipidemic hypertensive patients: comparison of rilmenidine and captopril.
Topics: Adrenergic alpha-Agonists; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Double-Blind Method; Female; Humans; Hyperlipoproteinemia Type II; Hypertension; Lipids; Male; Middle Aged; Oxazoles; Rilmenidine | 1995 |
2 other study(ies) available for captopril and Hyperlipoproteinemia Type II
| Article | Year |
|---|---|
Prevention with icatibant of anaphylactoid reactions to ACE inhibitor during LDL apheresis.
Topics: Adrenergic beta-Antagonists; Anaphylaxis; Blood Component Removal; Bradykinin; Captopril; Child; Female; Humans; Hyperlipoproteinemia Type II; Lipoproteins, LDL | 1994 |
Beneficial effects of ACE-inhibition with zofenopril on plaque formation and low-density lipoprotein oxidation in watanabe heritable hyperlipidemic rabbits.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Arteriosclerosis; Blood Platelets; Captopril; Female; Hyperlipoproteinemia Type II; Immunohistochemistry; Lipoproteins, LDL; Male; Rabbits | 1999 |